Hazard assessment of hexagonal boron nitride and hexagonal boron nitride reinforced thermoplastic polyurethane composites using human skin and lung cells.

2D materials Composites Cytotoxicity Life cycle perspective Omics

Journal

Journal of hazardous materials
ISSN: 1873-3336
Titre abrégé: J Hazard Mater
Pays: Netherlands
ID NLM: 9422688

Informations de publication

Date de publication:
22 May 2024
Historique:
received: 25 03 2024
revised: 14 05 2024
accepted: 20 05 2024
medline: 25 5 2024
pubmed: 25 5 2024
entrez: 24 5 2024
Statut: aheadofprint

Résumé

Hexagonal boron nitride (hBN) is an emerging two-dimensional material attracting considerable attention in the industrial sector given its innovative physicochemical properties. Potential risks are associated mainly with occupational exposure where inhalation and skin contact are the most relevant exposure routes for workers. Here we aimed at characterizing the effects induced by composites of thermoplastic polyurethane (TPU) and hBN, using immortalized HaCaT skin keratinocytes and BEAS-2B bronchial epithelial cells. The composite was abraded using a Taber® rotary abraser and abraded TPU and TPU-hBN were also subjected to photo-Fenton-mediated degradation mimicking potential weathering across the product life cycle. Cells were exposed to the materials for 24 h (acute exposure) or twice per week for 4 weeks (chronic exposure) and evaluated with respect to material internalization, cytotoxicity, and proinflammatory cytokine secretion. Additionally, comprehensive mass spectrometry-based proteomics and metabolomics (secretomics) analyses were performed. Overall, despite evidence of cellular uptake of the material, no significant cellular and/or protein expression profiles alterations were observed after acute or chronic exposure of HaCaT or BEAS-2B cells, identifying only few pro-inflammatory proteins. Similar results were obtained for the degraded materials. These results support the determination of hazard profiles associated with cutaneous and pulmonary hBN-reinforced polymer composites exposure.

Identifiants

pubmed: 38788582
pii: S0304-3894(24)01265-2
doi: 10.1016/j.jhazmat.2024.134686
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

134686

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Bengt Fadeel, Alberto Bianco, Maurizio Prato, Ester Vazquez, Peter Wick reports financial support was provided by Graphene Flagship. Alberto Bianco reports financial support was provided by French National Research Agency. Ester Vazquez reports financial support was provided by European Union. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Michela Carlin (M)

Department of Life Sciences, University of Trieste, Trieste, Italy.

Jasreen Kaur (J)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Dinu Zinovie Ciobanu (DZ)

Analytical Chemistry Facility, Italian Institute of Technology, Genoa, Italy.

Zhengmei Song (Z)

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, ISIS, 67000 Strasbourg, France.

Magnus Olsson (M)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Tiberiu Totu (T)

Laboratory for Particles-Biology Interactions, Federal Laboratory for Materials Science and Technology, (EMPA), St. Gallen, Switzerland; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland; Department of Health Sciences and Technology, Eidgenössische Technische Hochschule Zürich (ETH), Zurich, Switzerland.

Govind Gupta (G)

Laboratory for Particles-Biology Interactions, Federal Laboratory for Materials Science and Technology, (EMPA), St. Gallen, Switzerland.

Guotao Peng (G)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Viviana Jehová González (VJ)

Regional Institute of Applied Scientific Research (IRICA), University of Castilla-La Mancha, Ciudad Real, Spain.

Iwona Janica (I)

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, ISIS, 67000 Strasbourg, France.

Victor Fuster Pozo (VF)

Laboratory for Particles-Biology Interactions, Federal Laboratory for Materials Science and Technology, (EMPA), St. Gallen, Switzerland.

Savvina Chortarea (S)

Laboratory for Particles-Biology Interactions, Federal Laboratory for Materials Science and Technology, (EMPA), St. Gallen, Switzerland.

Marija Buljan (M)

Laboratory for Particles-Biology Interactions, Federal Laboratory for Materials Science and Technology, (EMPA), St. Gallen, Switzerland; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.

Tina Buerki-Thurnherr (T)

Laboratory for Particles-Biology Interactions, Federal Laboratory for Materials Science and Technology, (EMPA), St. Gallen, Switzerland.

Antonio Esau Del Rio Castillo (AED)

BeDimensional, Genoa, Italy.

Sanjay B Thorat (SB)

BeDimensional, Genoa, Italy.

Francesco Bonaccorso (F)

BeDimensional, Genoa, Italy.

Aurelia Tubaro (A)

Department of Life Sciences, University of Trieste, Trieste, Italy.

Ester Vazquez (E)

Regional Institute of Applied Scientific Research (IRICA), University of Castilla-La Mancha, Ciudad Real, Spain; Department of Organic Chemistry, Faculty of Science and Chemistry Technologies, University of Castilla-La Mancha, Ciudad Real, Spain.

Maurizio Prato (M)

Department of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste, Italy; Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Donostia-San Sebastian, Spain; Basque Foundation for Science (IKERBASQUE), Bilbao, Spain.

Andrea Armirotti (A)

Analytical Chemistry Facility, Italian Institute of Technology, Genoa, Italy.

Peter Wick (P)

Laboratory for Particles-Biology Interactions, Federal Laboratory for Materials Science and Technology, (EMPA), St. Gallen, Switzerland.

Alberto Bianco (A)

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, ISIS, 67000 Strasbourg, France. Electronic address: a.bianco@ibmc-cnrs.unistra.fr.

Bengt Fadeel (B)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: bengt.fadeel@ki.se.

Marco Pelin (M)

Department of Life Sciences, University of Trieste, Trieste, Italy. Electronic address: mpelin@units.it.

Classifications MeSH